August 1, 2008
Jacksonville, Fla. (August 4, 2008) - Radiation oncologist Daniel J. Indelicato, M.D., has joined the University of Florida Proton Therapy Institute and will treat cancer patients with a focus on sarcomas of the soft tissue and bone, cancer in children and breast cancer.
Indelicato most recently served as chief resident at the UF College of Medicine’s Department of Radiation Oncology. During his residency, Indelicato spent significant elective time at the UF Proton Therapy Institute and St. Jude Children’s Hospital in Memphis. Prior to his specialty training in radiation oncology, he completed an internship at Memorial Sloan-Kettering Cancer Center in New York.
“We are pleased to welcome Dr. Indelicato to our staff,” said Dr. Nancy Mendenhall, UF Proton Therapy Institute’s medical director. “His skill and experience compliment the strengths of our physicians, deepens our clinical research staff and broadens our capacity to treat more patients.”
Indelicato is an established cancer researcher, contributing to multiple studies involving sarcoma, breast cancer, prostate cancer, and pediatric cancer. His work spans various forms of radiotherapy, including proton therapy. His research has been published in a variety of peer-reviewed medical journals, including the International Journal of Radiation Oncology, Biology & Physics, Medical Physics, and Surgery, and he has been invited to present his findings at national and international medical conferences. He serves on the Emerging Technology Evaluation Subcommittee of the ASTRO Health Policy Council and he is on the Science Advisory Committee of the Lance Armstrong Foundation Young Adult Alliance .
A native of Gainesville, Fla., Indelicato comes from a family of physicians and nurses with ties to the UF College of Medicine.
“I chose radiation oncology because it was a chance to work with cancer patients in a field that is a convergence of medicine and technology,” said Indelicato. “Proton therapy provides patients significant advantages for cure and reduced risk of damaging side effects that may be common with other kinds of radiation treatment.”
Protons differ from X-rays commonly used in conventional radiation. X-rays enter the body at a high energy level, travel through the body to the tumor, and then exit the body on the other side, exposing all tissue in their path to damaging radiation. In contrast, protons enter the body at a low energy level and release most of their energy upon impact with the tumor, so there is no “exit” dosage of radiation to healthy tissue. This results in a low incidence of side effects and, especially in children, fewer long-term effects.
University of Florida Proton Therapy Institute, a 501 (c) 3 organization, is affiliated with the University of Florida College of Medicine (UF), a national leader in cancer treatment and research. A team of radiation oncologists, physicists, engineers and computer scientists, all faculty members at UF, delivers state-of-the-art cancer treatment and strives to set new standards for treating and curing the disease. More than 27,000 treatments have been delivered since opening in August 2006. For more information about UF Proton Therapy Institute, please visit www.floridaproton.org.